Method and pharmaceutical composition for obtaining the...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/57 (2006.01) A61K 9/16 (2006.01) A61P 15/06 (2006.01) A61P 15/12 (2006.01)

Patent

CA 2721509

The invention relates to the development of a method and pharmaceutical compositions for obtaining plasmatic progesterone levels in humans and for maintaining a plasmatic progesterone concentration between 42 and 3.5 ng/mL for eight days as well as maximum plasmatic concentrations (Cmax) between 12 and 42 ng/mL, sufficient for use in different therapeutic options that require said progesterone concentrations.

La presente invención se refiere al diseño de un método y composiciones farmacéuticas para lograr niveles plasmáticos de progesterona en humanos y mantener una concentración plasmática de progesterona entre 42 y 3.5 ng/mL durante 8 días así como concentraciones plasmáticas máximas (Cmax) entre 12 y 42 ng/mL, suficientes para su aplicación en diferentes opciones terapéuticas que requieren de dichas concentraciones de progesterona.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method and pharmaceutical composition for obtaining the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and pharmaceutical composition for obtaining the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and pharmaceutical composition for obtaining the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1865188

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.